We believe Prestige is in fine financial health. At the end of fiscal 2024, the company had roughly $46 million in cash and equivalents with about $1.1 billion in long-term debt. Majority of debt was ...

Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...

Prestige Consumer Healthcare Inc.’s PBH share price has surged by 14.78%, which has investors questioning if this is right ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

DELRAY BEACH, FL / ACCESS Newswire / February 4, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company"), is developing ...

In an era where wellness and natural health are paramount, CBD products have surged in popularity, captivating the attention ...

The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...

The US Food and Drug Administration has approved suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

Report Ocean’s recent report provides an accurate and comprehensive research analysis of the “Saudi Arabia Pediatric Healthcare Market” with a primary focus on the present and past market conditions.